アブストラクト
Japanese
Title | 胃癌手術における術後感染症対策, 早期回復を念頭においた周術期管理プログラムに関する前向き無作為比較試験 |
---|---|
Subtitle | 特集 : 外科感染症対策を念頭においた栄養管理 原著 |
Authors | 田中亮, 李相雄, 今井義朗, 本田浩太郎, 田中慶太朗, 内山和久 |
Authors (kana) | |
Organization | 大阪医科大学一般・消化器外科 |
Journal | 日本外科感染症学会雑誌 |
Volume | 17 |
Number | 2 |
Page | 75-81 |
Year/Month | 2020 / |
Article | 原著 |
Publisher | 日本外科感染症学会 |
Abstract | 「要旨:」【目的】胃癌手術におけるenhanced recovery after surgery(以下, ERAS(R))に基づいた周術期管理の効果を明らかにする. 【方法】根治切除可能な胃癌症例を対象として, 従来型クリニカルパスに沿った周術期管理を行うconventional群(C群)とERAS(R)に基づく管理を行うERAS(R)群(E群)に割り付けた. 主要評価項目は術後在院日数, 副次評価項目は術後合併症発生率, 術後1カ月以内再入院率, 体重減少率とした. 【結果】2013年7月から2015年6月まで148例を登録し, C群69例, E群73例が解析対象となった. プロトコールの完遂率はC群81.2%, E群87.7%であった. 術後在院日数の中央値はC群10日, E群9日であり, E群の在院日数は有意に短縮された(P=0.037). Clavien-Dindo分類Grade IIIの合併症はC群10例, E群3例であり, E群で有意に少なかった(P=0.042). 両群で1例の再入院を認めたが保存的治療で軽快した. 術後1週間および術後1カ月の体重に関して, E群で有意に体重減少が抑制された(P=0.020, 0.021). 【結論】胃癌手術におけるERAS(R)に基づいた周術期管理は在院日数を短縮するだけでなく, 術後合併症の減少, 体重減少の抑制にも寄与した. |
Practice | 臨床医学:外科系 |
Keywords | enhanced recovery after surgery, 早期回復, 体重減少, 活動量 |
English
Title | Perioperative management program for postoperative infection control and early recovery in gastric cancer surgery ; randomized controlled trial |
---|---|
Subtitle | |
Authors | Ryo Tanaka, Sang-Woong Lee, Yoshiro Imai, Kotaro Honda, Keitaro Tanaka, Kazuhisa Uchiyama |
Authors (kana) | |
Organization | Department of General and Gastroenterological Surgery, Osaka Medical College |
Journal | Journal of Japan Society for Surgical Infection |
Volume | 17 |
Number | 2 |
Page | 75-81 |
Year/Month | 2020 / |
Article | Original article |
Publisher | Japan Society for Surgical Infection |
Abstract | 【Introduction】 The feasibility of using the enhanced recovery after surgery (ERAS) program in patients with gastric cancer remains unclear. We evaluated the safety and efficacy of the ERAS protocol in such patients. 【Methods】 This study was a single-center, prospective randomized trial on patients with gastric cancer undergoing curative gastrectomy. The primary end point was the length of postoperative hospital stay. Secondary end points were the postoperative complication rate, readmission rates and weight loss. 【Results】 From July 2013 to June 2015, we randomized 148 patients into an ERAS group (n=73) and a conventional group (n=69) ; six patients withdrew. The completion rates of the protocol were 87.7 % for the ERAS group and 81.2 % for the conventional group. Postoperative hospital stay in the ERAS group was significantly shorter than that in the conventional group (9 vs. 10 days ; P=0.037). The ERAS group had a significantly lower rate of postoperative complications grade III or higher (4 vs. 15 per cent ; P=0.042). The ratio of body weight to preoperative weight at postoperative week 1 and at 1 month was higher in the ERAS group (0.962 vs. 0.957, P=0.020 ; and 0.951 vs. 0.937, P=0.021, respectively). 【Conclusion】 The ERAS program shortened the postoperative hospital stay after gastric cancer surgery, reduced the rate of complications and accelerated the recovery of good physical condition. |
Practice | Clinical surgery |
Keywords | enhanced recovery after surgery |
- 全文ダウンロード: 従量制、基本料金制の方共に770円(税込) です。
参考文献
- 1) Fearon KC, Ljungqvist O, Von Meyenfeldt M, et al : Enhanced recovery after surgery : a consensus review of clinical care for patients undergoing co-lonic resection. Clin Nutr 2005 ; 24 : 466-477
- 2) Kehlet H, Wilmore DW : Evidence-based surgical care and the evolution of fast-track surgery. Ann Surg 2008 ; 248 : 189-198
- 3) King PM, Blazeby JM, Ewings P, et al : The influ-ence of an enhanced recovery programme on clini-cal outcomes, costs and quality of life after sur-gery for colorectal cancer. Colorectal Dis 2006 ; 8 : 506-513
- 4) Varadhan KK, Neal KR, Dejong CH et al : The en-hanced recovery after surgery(ERAS) pathway for patients undergoing major elective open colorectal surgery : a meta-analysis of random-ized controlled trials. Clin Nutr 2010 ; 29 : 434-440
- 5) Gustafsson UO, Scott MJ, Schwenk W, et al : Guidelines for perioperative care in elective colon-ic surgery : enhanced recovery after surgery(ERAS(R)) Society recommendations. Clin Nutr 2012 ; 31 : 783-800
残りの14件を表示する
- 6) Mortensen K, Nilsson M, Slim K, et al : Consensus guidelines for enhanced recovery after gastrecto-my : enhanced recovery after surgery(ERAS(R)) society recommendations. Br J Surg 2014 ; 101 : 1209-1229
- 7) Kim HH, Han SU, Kim MC, et al : Long-term re-sults of laparoscopic gastrectomy for gastric can-cer : a large-scale case-control and case-matched Korean multicenter study. J Clin Oncol 2014 ; 32 : 627-633
- 8) Inaki N, Etoh T, Ohyama T, et al : A multi-insti-tutional, prospective, phase II feasibility study of laparoscopy-assisted distal gastrectomy with D2 lymph node dissection for locally advanced gastric cancer(JLSSG0901). World J Surg 2015 ; 39 : 2734-2741
- 9) Lee SW, Nomura E, Bouras G, et al : Long-term oncologic outcomes from laparoscopic gastrectomy for gastric cancer : a single-center experience of 601 consecutive resections. J Am Coll Surg 2010 ; 211 : 33-40
- 10) Sano T, Sasako M, Yamamoto S, et al : Gastric cancer surgery : morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphad-enectomy-Japan Clinical Oncology Group study 9501. J Clin Oncol 2004 ; 22 : 2767-2773
- 11) Degiuli M, Sasako M, Calgaro M, et al : Morbidity and mortality after D1 and D2 gastrectomy for cancer : interim analysis of the Italian Gastric Can-cer Study Group(IGCSG) randomised surgical tri-al. Eur J Surg Oncol 2004 ; 30 : 303-308
- 12) Katai H, Sasako M, Fukuda H, et al : Safety and feasibility of laparoscopy-assisted distal gastrecto-my with suprapancreatic nodal dissection for clini-cal stage I gastric cancer : a multicenter phase II trial(JCOG 0703). Gastric Cancer 2010 ; 13 : 238-244
- 13) Kurita N, Miyata H, Gotoh M, et al : Risk model for distal gastrectomy when treating gastric can-cer on the basis of data from 33,917 japanese pa-tients collected using a nationwide web-based data entry system. Ann Surg 2015 ; 262 : 295-303
- 14) Hur H, Kim SG, Shim JH, et al : Effect of early oral feeding after gastric cancer surgery : a result of randomized clinical trial. Surgery 2011 ; 149 : 561-568
- 15) 田村茂行, 竹野 淳, 谷口博一, ほか : 幽門側胃切除におけるドレーン省略条件の検討. 日外感染症会誌 2013 : 10 : 369-374
- 16) Shimoike N, Akagawa S, Yagi D, et al : Laparo-scopic gastrectomy with and without prophylactic drains in gastric cancer : a propensity score-matched analysis. World J Surg Oncol 2019 ; 17 : 144
- 17) Sakuramoto S, Sasako M, Yamaguchi T, et al : Ad-juvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 2007 ; 357 : 1810-1820.
- 18) Aoyama T, Yoshikawa T, Shirai J, et al : Body weight loss after surgery is an independent risk factor for continuation of S-1 adjuvant chemo-therapy for gastric cancer. Ann Surg Oncol 2013 ; 20 : 2000-2006
- 19) Aoyama T, Kawabe T, Fujikawa H, et al : loss of lean body mass as an independent risk factor for continuation of S-1 adjuvant chemotherapy for gastric cancer. Ann Surg Oncol 2015 ; 22 : 2560-2566